Vaccine research and development to advance pandemic and seasonal influenza preparedness and response : lessons from COVID-19 /

Saved in:
Bibliographic Details
Imprint:Washington, DC : National Academies Press, [2022]
Description:1 online resource (1 PDF file (xxiii, 153 pages)) : illustrations, color maps, charts.
Language:English
Series:Consensus study report
Consensus study report.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/13914715
Hidden Bibliographic Details
Other authors / contributors:Soltani, Hoda, editor.
Subbarao, Kanta, editor.
Bond, Enriqueta C., editor.
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response, issuing body.
ISBN:9780309087827
0309087821
9780309087810
0309087813
Notes:Includes bibliographical references.
This activity was supported by a contract between the National Academy of Sciences and the Office of Global Affairs with the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
Description based on online resource; title from PDF title page (viewed July 5, 2022).
Summary:The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.
Other form:Print version: Medicine, National Academy of Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response Washington, D.C. : National Academies Press,c2022 9780309087810

MARC

LEADER 00000cam a2200000 i 4500
001 13914715
006 m o d
007 cr cn|||||||||
008 220405s2022 dcua ob 000 0 eng
005 20241219145251.2
010 |a  2021950193 
035 |a (OCoLC)1296425995  |z (OCoLC)1295276451 
035 9 |a (OCLCCM-CC)1296425995 
040 |a NLM  |b eng  |e rda  |c NLM  |d N$T  |d TXM  |d EBLCP  |d OCLCQ  |d OCLCO 
016 7 |a 9918382878206676  |2 DNLM 
019 |a 1295276451 
020 |a 9780309087827  |q (electronic bk.) 
020 |a 0309087821  |q (electronic bk.) 
020 |z 9780309087810 
020 |z 0309087813 
042 |a pcc 
050 4 |a RA644.C67  |b V33 2022 
060 0 0 |a WC 515 
049 |a MAIN 
245 0 0 |a Vaccine research and development to advance pandemic and seasonal influenza preparedness and response :  |b lessons from COVID-19 /  |c Hoda Soltani, Kanta Subbarao, Enriqueta Bond editors ; Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response. Board on Global Health, Health and Medicine Division. 
264 1 |a Washington, DC :  |b National Academies Press,  |c [2022] 
300 |a 1 online resource (1 PDF file (xxiii, 153 pages)) :  |b illustrations, color maps, charts. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Consensus study report 
504 |a Includes bibliographical references. 
520 3 |a The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic. The rapid development of COVID-19 vaccines has demonstrated what is possible with extensive data sharing, researchers who have the necessary resources and novel technologies to conduct and apply their research, rolling review by regulators, and public-private partnerships. As demonstrated throughout the response to COVID-19, the process of research and development of novel vaccines can be significantly optimized when stakeholders are provided with the resources and technologies needed to support their response. Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee's findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science. 
536 |a This activity was supported by a contract between the National Academy of Sciences and the Office of Global Affairs with the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 |a Description based on online resource; title from PDF title page (viewed July 5, 2022). 
505 0 |a Front Matter -- Summary -- 1. Introduction -- 2. Basic and Translational Science -- 3. Clinical Science -- 4. Manufacturing Science -- 5. Regulatory Science -- 6. A Blueprint for Action -- Appendix A: Committee Biographies -- Appendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Staff and Consultant Biographies -- Appendix D: Public Meeting Agendas. 
650 0 |a COVID-19 (Disease)  |0 http://id.loc.gov/authorities/subjects/sh2020000570 
650 0 |a Influenza vaccines.  |0 http://id.loc.gov/authorities/subjects/sh85066132 
650 0 |a COVID-19 vaccines.  |0 http://id.loc.gov/authorities/subjects/sh2022005580 
650 1 2 |a Influenza, Human  |x prevention & control  |0 https://id.nlm.nih.gov/mesh/D007251Q000517 
650 1 2 |a Influenza Vaccines  |0 https://id.nlm.nih.gov/mesh/D007252 
650 2 2 |a COVID-19  |x prevention & control  |0 https://id.nlm.nih.gov/mesh/D000086382Q000517 
650 2 2 |a COVID-19 Vaccines  |0 https://id.nlm.nih.gov/mesh/D000086663 
650 2 2 |a Vaccine Development  |0 https://id.nlm.nih.gov/mesh/D000087506 
651 2 |a United States  |0 https://id.nlm.nih.gov/mesh/D014481 
650 2 |a COVID-19  |0 https://id.nlm.nih.gov/mesh/D000086382 
650 6 |a COVID-19. 
650 6 |a Vaccins antigrippaux. 
650 6 |a Vaccins contre la COVID-19. 
650 7 |a COVID-19 (Disease)  |2 fast 
650 7 |a Influenza vaccines  |2 fast 
700 1 |a Soltani, Hoda,  |e editor. 
700 1 |a Subbarao, Kanta,  |e editor. 
700 1 |a Bond, Enriqueta C.,  |e editor. 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.).  |b Committee on Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response,  |e issuing body.  |0 http://id.loc.gov/authorities/names/n2022182622 
776 0 8 |i Print version:  |a Medicine, National Academy of  |t Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response  |d Washington, D.C. : National Academies Press,c2022  |z 9780309087810 
830 0 |a Consensus study report.  |0 http://id.loc.gov/authorities/names/n2017188206 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=3165656  |y eBooks on EBSCOhost 
929 |a oclccm 
999 f f |i 066a3666-046b-4c76-b75c-ea2f0acfcafd  |s d57cea4f-2488-4f96-85ce-fc3a4a565919 
928 |t Library of Congress classification  |a RA644.C67V33 2022  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=3165656  |z eBooks on EBSCOhost  |g ebooks  |i 14057736